Stable formulations of nerve growth factor

Details Stable formulations of nerve growth factor Stable formulations of nerve growth factor

2006-07-11

2006-07-11

Hayes, Robert C. (Department: 1649)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S399000

Reexamination Certificate

active

07074763

ABSTRACT:
Aqueous formulations of nerve growth factor suitable for lyophilization and subsequent reconstitution in which nerve growth factor is admixed with sugars and buffer are provided.

REFERENCES:
patent: 5096885 (1992-03-01), Pearlman et al.
patent: 5210185 (1993-05-01), DelaValle et al.
patent: 0 267 015 (1988-05-01), None
patent: 0 308 238 (1989-03-01), None
Arakawa et al., “Stabilization of Protein Structure by Sugars”, Biochemistry, 21: 6536-6544 (1982).
Calbiochem Catalog, p. 219 (1992).
Diemetal (eds.), “Scientific Tables”, Ciba-Geigy, Ltd., Basle, Switzerland, pp. 271-273, 280-281, and 528-529 (1970).
Gregouadis et al., Trends in Biotech., 11: 440-442 (1993).
Pikal, M.J., “Freeze-Drying of Proteins-Part II: Formulation Selection”, BioPharm., pp. 26-30, (Oct. 1990).
Pignatti et al., “Solution Properties of β Nerve Growth Factor Protein and Some of its Derivatives”, J. Neurochem., 25: 155-159 (1975).
Wang et al., “Parenteral Formulations of Proteins and Peptides: Stability and Stabilizers”, J. Parenter. Sci. Tech., 42: S3-S26 (1988).
Allen, S.J., et al, “Recombinant human nerve growth factor for clinical trials: protein expression, purification, stability and characterization of binding to infusion pumps”,J. Biochem Biophys Methods, 2001, 47:239-55.
Barnett, J., et al., “Physiochemical characterization of Recombinant Human Nerve Growth Factor Produced in Insect Cells with a Baculovirus Vector”,J. Neurochem., 1991, 57(3):1052-61.
Bruce, G., et al., “Production and Characterization of Biologically Active Recombinant Human Nerve Growth Factor”,Neurobiol Aging, 1989 10(1):89-94.
Eng, M. et al, “Formulation Development and Primary Degradation Pathways for Recombinant Human Nerve Growth Factor”,Anal. Chem., 1997, 69(20):4184-4190.
Furukawa, Y., et al., “Nerve Growth Factor Secreted by Mouse Heart Cells in Culture”,J. Of Bio. Chem., 1984, 259(2):1259-1264.
Harper, G.P., et al, “The Purification of Nerve Growth Factor from Bovine Seminal Plasma”,J. of Bio. Chem., 1982, 257(14):8541-8548.
Iwane, M., et al., “Production, Purification and Characterization of Biologically Active Recombinant Human Nerve Growth Factor”,Biochem, Biophys, Res. Commun., 1990, 171(1):116-22.
Lam, X.M., et al., “Encapsulation and Stabilization of Nerve Growth Factor into Poly(lactic-co-glycolic) Acid Microspheres”, J. Pharm Sci., 2001, 90(9):1356-65.
Pattison, S.E., et al., “On the Relationship of Zinc Ion to the Structure and Function of the 7S Nerve Growth Factor Protein”,Biochemistry, 1975 (14(12):2733-9.
Perez-Polo, J.R., et al., “The Preparation and Properties of Nerve Growth Factor Protein at Alkaline pH”,Neurobiology, 1975, 5(6):329-38.
Yang, T.H., et al., “Effect of Zinc Binding and Precipitation on Structures of Recombinant Human Growth Hormone and Nerve Growth Factor”,J. Pharm. Sci., 89(11):1480-5 (2000).

Affiliated with

Also associated with

Rating

Stable formulations of nerve growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable formulations of nerve growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable formulations of nerve growth factor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3597670